Last updated on July 2010

Platelet Transfusion in Acute Intracerebral Hemorrhage


Brief description of study

- To prove whether use of antiplatelet agents results into a rapid enlargement of hematoma after onset of acute intracerebral hemorrhage. - To prove the efficacy and safety of platelet transfusion for prevention of hematoma growth in patients who were stricken by acute intracerebral hemorrhage while being on antiplatelet medication.

Detailed Study Description

- Hematoma growth is a well-known powerful determinant of mortality and poor outcome after intracerebral hemorrhage. - Some observations suggest that previous use of antiplatelet agents associates with rapid hematoma enlargement and poor outcome after cerebral hemorrhage. - Immediate platelet transfusion for such patients may prevent hematoma growth but also cause thromboembolic complications.

Clinical Study Identifier: NCT00699621

Contact Investigators or Research Sites near you

Start Over

Juha T Huhtakangas, MD

Department of Neurology, Oulu University Hospital
Oulu, Finland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.